Edwards Lifesciences (EW) CFO covers taxes with 3,034 withheld shares

Rhea-AI Filing Summary

Edwards Lifesciences Corp Chief Financial Officer Scott B. Ullem reported routine share dispositions to cover tax obligations tied to equity compensation. On May 7 and 8, a total of 3,034 common shares were withheld at prices of $83.20 and $82.76 per share. These were issuer tax-withholding transactions, not open-market sales. Ullem now holds 37,914 shares directly and 266,318 shares indirectly through a trust.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Ullem Scott B.

Role CVP, Chief Financial Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	1,661	$82.76	$137K
Tax Withholding	Common Stock	1,373	$83.20	$114K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 37,914 shares (Direct, null); Common Stock — 266,318 shares (Indirect, By Trust)

Footnotes (1)

Key Figures

Tax-withheld shares May 8: 1,661 shares at $82.76 Tax-withheld shares May 7: 1,373 shares at $83.20 Total tax-withheld shares: 3,034 shares +5 more

8 metrics

Tax-withheld shares May 8 1,661 shares at $82.76 Common Stock, tax-withholding disposition on May 8, 2026

Tax-withheld shares May 7 1,373 shares at $83.20 Common Stock, tax-withholding disposition on May 7, 2026

Total tax-withheld shares 3,034 shares Sum of F-code tax-withholding dispositions

Direct holdings after May 8 37,914 shares Total common shares directly owned following latest transaction

Direct holdings after May 7 39,575 shares Total common shares directly owned following May 7 tax withholding

Indirect trust holdings 266,318 shares Common shares held indirectly "By Trust" as of May 7, 2026

Price per share May 8 $82.76 per share Value used for 1,661 tax-withheld shares on May 8, 2026

Price per share May 7 $83.20 per share Value used for 1,373 tax-withheld shares on May 7, 2026

Key Terms

tax-withholding disposition, Common Stock, By Trust, Form 4

4 terms

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Common Stock financial

""security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

By Trust financial

""nature_of_ownership": "By Trust""

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ullem Scott B.

(Last) (First) (Middle)

ONE EDWARDS WAY

(Street)

IRVINE CALIFORNIA 92614

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Edwards Lifesciences Corp [ EW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CVP, Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/07/2026		F		1,373	D	$83.2	39,575	D
Common Stock	05/08/2026		F		1,661	D	$82.76	37,914	D
Common Stock								266,318	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

	Linda J. Park, Attorney-in-Fact	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Edwards Lifesciences (EW) CFO Scott Ullem report in this Form 4?

Scott Ullem reported routine tax-withholding dispositions of company stock. A total of 3,034 Edwards Lifesciences common shares were withheld by the issuer to satisfy tax obligations related to equity compensation, rather than sold on the open market.

Were Scott Ullem’s Edwards Lifesciences (EW) transactions open-market sales?

No, the transactions were not open-market sales. Both entries used code F, meaning shares were delivered back to Edwards Lifesciences to cover tax liabilities on equity awards, a common administrative mechanism rather than discretionary selling activity.

How many Edwards Lifesciences (EW) shares does Scott Ullem hold after these transactions?

After these tax-withholding events, Scott Ullem holds 37,914 Edwards Lifesciences common shares directly. He also has an indirect position of 266,318 common shares held "By Trust," reflecting additional beneficial ownership through a trust structure.

What is the significance of the 3,034 Edwards Lifesciences (EW) shares withheld for taxes?

The 3,034 withheld shares represent shares returned to Edwards Lifesciences to satisfy tax obligations on vested equity. This is recorded as a disposition but is generally viewed as routine compensation administration, not a signal of insider sentiment about the stock.

What do “direct” and “By Trust” ownership mean for Edwards Lifesciences (EW) shares?

Direct ownership refers to shares held personally in Scott Ullem’s name. “By Trust” indicates an indirect holding, where 266,318 Edwards Lifesciences shares are owned through a trust, but are still reported as part of his beneficial ownership on the Form 4.